1. Home
  2. KYMR vs HIMX Comparison

KYMR vs HIMX Comparison

Compare KYMR & HIMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • HIMX
  • Stock Information
  • Founded
  • KYMR 2015
  • HIMX 2001
  • Country
  • KYMR United States
  • HIMX Taiwan
  • Employees
  • KYMR N/A
  • HIMX N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • HIMX Semiconductors
  • Sector
  • KYMR Health Care
  • HIMX Technology
  • Exchange
  • KYMR Nasdaq
  • HIMX Nasdaq
  • Market Cap
  • KYMR 1.8B
  • HIMX 1.5B
  • IPO Year
  • KYMR 2020
  • HIMX 2006
  • Fundamental
  • Price
  • KYMR $29.64
  • HIMX $8.15
  • Analyst Decision
  • KYMR Buy
  • HIMX Buy
  • Analyst Count
  • KYMR 15
  • HIMX 1
  • Target Price
  • KYMR $55.47
  • HIMX $15.00
  • AVG Volume (30 Days)
  • KYMR 650.3K
  • HIMX 1.3M
  • Earning Date
  • KYMR 05-09-2025
  • HIMX 05-08-2025
  • Dividend Yield
  • KYMR N/A
  • HIMX 9.08%
  • EPS Growth
  • KYMR N/A
  • HIMX 87.58
  • EPS
  • KYMR N/A
  • HIMX 0.50
  • Revenue
  • KYMR $58,885,000.00
  • HIMX $914,385,000.00
  • Revenue This Year
  • KYMR $32.80
  • HIMX $1.85
  • Revenue Next Year
  • KYMR $8.88
  • HIMX $8.82
  • P/E Ratio
  • KYMR N/A
  • HIMX $16.33
  • Revenue Growth
  • KYMR N/A
  • HIMX 0.62
  • 52 Week Low
  • KYMR $19.45
  • HIMX $5.12
  • 52 Week High
  • KYMR $53.27
  • HIMX $13.91
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 48.27
  • HIMX 54.15
  • Support Level
  • KYMR $28.06
  • HIMX $8.03
  • Resistance Level
  • KYMR $30.28
  • HIMX $8.76
  • Average True Range (ATR)
  • KYMR 1.65
  • HIMX 0.33
  • MACD
  • KYMR -0.19
  • HIMX -0.01
  • Stochastic Oscillator
  • KYMR 27.96
  • HIMX 24.69

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About HIMX Himax Technologies Inc.

Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm's revenue is derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, and scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.

Share on Social Networks: